Liver toxicity alert
Unapproved Retatrutide
The warning highlights acute liver injury cases in Victoria linked to unapproved peptides marketed as Retatrutide, Reta, R-10 and R-20.

Important safety warning
Patient education warning about unapproved substances, backyard peptides, online peptide sellers, social-media sourcing, incorrect dosing, contamination and substances that have not been assessed for safety, quality or effectiveness in Australia.
Read before considering any unapproved substance
The warning PDF covers acute liver injury linked to unapproved Retatrutide in Victoria, possible undisclosed contaminants, infection risk, local tissue damage, overdose risk, cardiac events, lack of human safety data, possible cancer-risk concerns and illegal unregulated sourcing channels.
Liver toxicity alert
The warning highlights acute liver injury cases in Victoria linked to unapproved peptides marketed as Retatrutide, Reta, R-10 and R-20.
Severe health risk
Reported risks include severe vomiting, abdominal cramping, chest pain, excessive dosing, bacterial contamination, tissue injury and rare limb or digit amputation.
Unverified purity
Black-market substances may have no real human safety data, incorrect concentrations, impurities and no Australian medical safety oversight.
This page is for patient education and safety awareness only. It does not replace medical advice, diagnosis, treatment, emergency care or a consultation with a qualified health practitioner.